Early Detection of Anaemia During the Maternity (anémie)

The Early Detection of Anaemia During the Maternity Decreases the Anaemia at the End of the Maternity.

Estimate the efficiency of a strategy of premature screening of the maternal anaemia during the first quarter of pregnancy versus the usual strategy of screening of the anaemia during the sixth month.

Study Overview

• Status: Completed
• Conditions: Anemia
• Intervention / Treatment: Biological: dosage of the NFS and iron

Detailed Description

A part of the patient will have a NFS and dosage of the cast-iron, during the results of the beginning of the pregnancy at the first quarter.

The other part of the patients will have a NFS and at the first quater of the pregnancy.

All the patient will have a NFS at the results of the sixth month of the pregnancy.

A NFS will be done during the results at the end of the pregnancy like we do now.

Then a NFS at 48 hours after the birth. A treatment with iron will be done and according to the results

• Study Type: Interventional
• Enrollment (Actual): 80
• Phase: Phase 3

Contacts and Locations

Study Locations

• France
  • Limousin
    • Limoges, Limousin, France, 87000
      • CHU Limoges

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 55 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Female

Description

Inclusion Criteria:

• Every patient followed at the HME at the beginnig of the pregnancy

Exclusion Criteria:

• pregnency women who don't speak french
• pregnancy women affected by béta thalassemia
• pregnancy woman having had a périconceptionnel treatment against the anaemia

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Diagnostic
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: NFS and iron in the first quater; first arm: dosage NFS and iron during the beginning of the pregnancy then in the sixth month of pregnancy then in th delivery.	Biological: dosage of the NFS and iron; a blood test will be made.
Experimental: No NFS and iron in the first quater; second arm: dosage NFS and iron during the sixth month of pregnancy then in th delivery. No dosage of NFS and iron during the beginning of the pregnancy	Biological: dosage of the NFS and iron; a blood test will be made.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
primary outcomes: is the rate of heamophilia at the end of the pregnancy.	six months

Secondary Outcome Measures

Outcome Measure	Time Frame
Secondary outcomes: - the percent of treatment of intravenous irons during the pregnancy and the following layers. - the percent of transfusion and the following layers.	6 months

Collaborators and Investigators

• Sponsor: University Hospital, Limoges
• Investigators: Principal Investigator: Vincelot anne, MD, Limoges UH

Study record dates

Study Major Dates

• Study Start: January 1, 2009
• Primary Completion (Actual): December 1, 2009
• Study Completion (Actual): December 1, 2009

Study Registration Dates

• First Submitted: January 20, 2009
• First Submitted That Met QC Criteria: January 21, 2009
• First Posted (Estimate): January 22, 2009

Study Record Updates

• Last Update Posted (Estimate): August 22, 2016
• Last Update Submitted That Met QC Criteria: August 19, 2016
• Last Verified: September 1, 2009

More Information

Terms related to this study

• Keywords: aneamia; aneamia during the maternity
• Additional Relevant MeSH Terms: Hematologic Diseases; Anemia
• Other Study ID Numbers: I08009